Drug Information

Drug General Information
Drug ID
D0P3ZN
Former ID
DNCL003385
Drug Name
RDEA3170
Indication Hyperuricaemia [ICD9: 274, 274.00274.1274.8274.9, 790.6; ICD10:E79.0, M10] Phase 2 [524664]
Company
AstraZeneca
Target and Pathway
Target(s) Solute carrier family 22 member 12 Target Info Modulator [544332]
WikiPathways Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 524664ClinicalTrials.gov (NCT02078219) Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia. U.S. National Institutes of Health.
Ref 544332The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol. 2013; 14: 164.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.